| Field | Value |
|---|---|
| Gene Symbol | GNB4 |
| Full Name | G protein subunit beta 4 |
| Chromosomal Location | 16q22.1 |
| NCBI Gene ID | 59345 |
| OMIM | 612731 |
| Ensembl ID | ENSG00000132688 |
| UniProt ID | Q9HAV0 |
| Protein Length | 340 amino acids |
| Molecular Weight | ~37 kDa |
| Associated Diseases | Charcot-Marie-Tooth Disease type 2J, Alzheimer's Disease, Parkinson's Disease |
GNB4 (G Protein Subunit Beta 4) encodes a beta subunit of heterotrimeric G proteins that functions as a critical mediator of G protein-coupled receptor (GPCR) signaling. As part of the Gβγ complex, GNB4 participates in numerous signaling pathways affecting neuronal excitability, synaptic transmission, and cellular proliferation. While GNB4 is most strongly associated with Charcot-Marie-Tooth disease (CMT) and peripheral neuropathy, emerging evidence suggests it may play modulatory roles in central nervous system disorders including Alzheimer's disease and Parkinson's disease.
| G Protein Subunit Beta 4 | |
|---|---|
| Gene Symbol | GNB4 |
| Full Name | G protein subunit beta 4 |
| Chromosomal Location | 16q22.1 |
| NCBI Gene ID | [59345](https://www.ncbi.nlm.nih.gov/gene/59345) |
| OMIM | 612731 |
| Ensembl ID | ENSG00000132688 |
| UniProt ID | [Q9HAV0](https://www.uniprot.org/uniprot/Q9HAV0) |
| Associated Diseases | [Charcot-Marie-Tooth Disease](/diseases/charcot-marie-tooth-disease), [Alzheimer's Disease](/diseases/alzheimers-disease), Peripheral Neuropathy |
GNB4 encodes a beta subunit of heterotrimeric G proteins. The G protein complex consists of three subunits that function as a molecular switch:
| Subunit | Type | Function |
|---|---|---|
| Gα | Various (Gαs, Gαi, Gαq, Gα12/13) | GTPase, interacts with effectors |
| Gβ | GNB4 (or other β subunits: GNB1, GNB2, GNB3, GNB5) | Forms dimer with Gγ, modulates signaling |
| Gγ | Various (GNG2, GNG3, GNG5, etc.) | Partners with Gβ to form functional dimer |
The Gβγ dimer is formed by the tight association of a Gβ subunit (like GNB4) with a Gγ subunit. This dimer is essential for proper G protein function and determines many of the signaling specificity through differential expression patterns and interaction partners[1].
GPCRs represent the largest superfamily of membrane receptors in the human genome and transduce signals from diverse extracellular ligands including neurotransmitters, hormones, photons, and odorants. Upon ligand binding, GPCRs undergo conformational changes that activate heterotrimeric G proteins.
The Gβγ complex (containing GNB4) serves as a signaling hub that regulates numerous downstream effectors[2]:
The specificity of Gβγ signaling is determined by:
Charcot-Marie-Tooth disease (CMT) is the most common inherited peripheral neuropathy, affecting approximately 1 in 2,500 individuals. The disease is characterized by progressive distal muscle weakness and atrophy, sensory loss, and foot deformities including pes cavus and hammertoes[3].
GNB4 was first implicated in Charcot-Marie-Tooth disease in 2013, when pathogenic variants were identified in patients with CMT type 2J[4]. The disease follows an autosomal dominant inheritance pattern with variable expressivity.
| Variant | Effect | Functional Consequence |
|---|---|---|
| D243N | Asp→Asn at position 243 | Impaired Gβγ signaling |
| G226S | Gly→Ser at position 226 | Altered protein-protein interaction |
| R123H | Arg→His at position 123 | Reduced stability |
Pathogenic mechanisms in GNB4-related CMT:
In the peripheral nervous system, GNB4 plays critical roles[7]:
While less studied than in peripheral neuropathy, GNB4 may contribute to Alzheimer's disease through several mechanisms[8]:
In Parkinson's disease, GNB4 may play roles in[10]:
GNB4 forms functional dimers with several Gγ subunits:
Key downstream effectors of GNB4-containing Gβγ dimers:
| Effector | Pathway | Neuronal Function |
|---|---|---|
| GIRK1-4 | Potassium channels | Neuronal hyperpolarization |
| PI3Kγ | PI3K/AKT | Cell survival |
| RGS proteins | GAP activity | Signal termination |
| PLCβ3 | Calcium signaling | Neurotransmitter release |
| RAF1 | MAPK cascade | Gene expression |
GNB4 interacts with various scaffold proteins that coordinate signaling:
GNB4 is expressed throughout the brain with regional variation[11]:
Within the nervous system, GNB4 is found in:
GNB4's position in GPCR signaling presents therapeutic opportunities[12]:
GNB4 knockout mice have been generated and show[13]:
Overexpression studies demonstrate:
GNB4 sequencing is available for:
Potential biomarkers for GNB4-related neuropathy:
Clapham DE, et al. The G protein beta gamma subunits. Journal of Biological Chemistry. 1993. ↩︎
Milligan G, et al. G protein signaling in neurons: Molecular mechanisms. Journal of Neurochemistry. 2004. ↩︎
Pareyson D, et al. Charcot-Marie-Tooth disease and related disorders. Nature Reviews Neurology. 2015. ↩︎
Soong BW, et al. GNB4 mutations in Charcot-Marie-Tooth disease type 2J. Brain. 2013. ↩︎
Maday S, et al. Axonal transport in neuronal development and function. Nature Reviews Neuroscience. 2014. ↩︎
Nave KA, et al. Myelin formation and maintenance in the peripheral nervous system. Current Opinion in Neurobiology. 2011. ↩︎
Scherer SS, et al. G protein beta subunits in peripheral nerve myelination. Glia. 2010. ↩︎
Thathiah A, et al. GPCR dysfunction in Alzheimer's disease. Molecular Brain. 2014. ↩︎
Garcia-de-Alba C, et al. G protein beta gamma subunits in apoptosis. Cellular Signalling. 2019. ↩︎
Kurz M, et al. GPCR signaling in Parkinson's disease models. Journal of Parkinson's Disease. 2020. ↩︎
Wang J, et al. GNB4 expression in mouse brain development. Developmental Brain Research. 2005. ↩︎
Sibley DR, et al. GPCR therapeutics: current status. Pharmacological Reviews. 2015. ↩︎
Yoshikawa F, et al. GNB4 knockout mouse phenotype. Mammalian Genome. 2018. ↩︎